Could a brazilian superfruit ease kidney disease complications?
NCT ID NCT06394531
First seen May 15, 2026 · Last updated Jun 21, 2026 · Updated 4 times
Summary
This study tests whether a supplement made from jaboticaba peel can help people with chronic kidney disease by reducing inflammation, oxidative stress, and gut bacteria imbalances. Thirty adults with kidney disease will take either the jaboticaba extract or a placebo for one month. Researchers will measure changes in blood and stool samples to see if the supplement has any beneficial effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Denise Mafra
Rio de Janeiro, Rio de Janeiro, 22260050, Brazil
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Jaboticaba peel extract (a dietary supplement rich in phenolic compounds)
What this could lead to
If it works, this could point toward a simple, natural supplement to help manage inflammation and gut health in people with chronic kidney disease.
What could go wrong
This is a very small, early-stage trial with only 30 people. The supplement may show no benefit over placebo, and results may not apply to all kidney disease patients.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.